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fragility and increased risk of fracture.4 Those with 
osteroporosis are commonly at high risk for fracture 
of pelvis, spine, and lower arms.5 Currently, there 
are 200 millions of people with osteoporosis.6 This 
disease was diagnosed using bone densitometry and 
measured according to the criteria from WHO with 
T score for post-menopause women and Z-score for 
younger people.4 
Decreased bone densitiy in hemophilia was fi rst 
reported by Gallacher et al in 1994.7 A few studies 
after reported the same results in adults and children 
and it was later supported with a meta-analysis 
study.7-14 Because bone density is related with the 
risk of fracture, hemophilic patients with decreased 
bone density will have increased risk of fracture. 
In hemophilia, fracture is a complex problem 
because of its morbidity and good hemostasis 
is needed for perioperative and rehabilitative 
period.1 Its management also needs cooperation 
between hematologists, surgeons, and medical 
rehabilitationists, besides expensive billing caused 
by coagulation factor concentrates.15-17 They are 
become the main reason of risk factor identifi cation 
hemophilia to prevent osteoporosis and fracture. 
A number of studies about decreased bone 
density and related factors were done in various 
countries and regions.9,10,14,18,19,20 This studies of 
osteoporosis in adults with hemophilia reported 
consistent result about decreased bone density in 
hemophilic patients compared with their normal 
counterpart. Unfortunately, these studies used 
T-score to defi ne osteoporosis in young subjects 
and their Z-score cut-off points were different from 
recommendations in guidelines. 14,18,19 They also had 
different characteristics compared with Indonesian 
patients, so those results could not be applied here. 
Because of those limitations, this study was done to 
understand the proportion of decreased bone density 
in hemophilia and the patients’ characteristics in 
Indonesia.
METHODS
This is a cross-sectional study to estimate the 
proportion of decreased bone density and to learn 
the patients’ characteristics. The study was done 
from June 2012 – November 2012 in Hematology-
Oncology outpatient clinic, Cipto Mangunkusumo 
Hospital. 
ABSTRACT
Background: Hemophilia can cause musculoskeletal 
complications and decreased bone density is one of 
those complications. The profile of hemophilic patients 
with decreased bone density in Indonesia is still 
unknown.
Objective: To estimate the proportion of decreased 
bone density hemophilia and to learn the characteristics 
of hemophilic patients with decreased bone density. 
Methods: This is a cross-sectional study done in 
June - November 2012. Subjects were adult hemophilic 
patients from 19-50 years old in Hematology- Oncology 
outpatient clinic Cipto Mangunkusumo Hospital. 
Estimated variables were bone density mass, age, body 
mass index, physical activity, arthropathy, substitution 
therapy, HIV, and HCV infection. 
Result: 63 subjects were included in the study with 
median age of 26 years old. The proportion of decreased 
bone density in hemophilia was 6.3%. Subjects with 
decreased bone density were younger (19 years old 
vs 26 years old), have lower BMI (18,6 + 2,8 kg/m2 
vs 21,5 + 3,8 kg/m2), used more substitution therapy 
(4047 IU/month vs 2000 IU/month), and have better 
clinical arthropathy score. HCV infection happened on 
25% subjects with decreased bone density while HIV 
was on 1.6% of subjects. 
Conclusion: Decreased bone density was found in 6.3% 
of subjects with hemophilia. They were younger, have 
lower BMI, better joint score, lower infection caused by 
transfusion, and more bleeding compared with subjects 
with normal bone density. 
Hemophilia is a disorder of blood coagulation 
caused by defi ciency of coagulation factor VIII 
(hemophilia A) or factor IX (hemophilia B). It is 
linked by mutation in X chromosom and is found 
in 1 of 10,000 births. Hemophilia A dominates 
the prevalence with more than 80-85% cases. 1 
According to the survey data by World Federation of 
Hemophilia (WFH) in 105 countries in 2009, there 
were 150,000 cases of hemophilia.2 Complications 
from hemophilia were caused by the disease itself or 
because of its treatment. One of the most common 
complications in hemophilia was musculoskeletal 
problems, and osteoporosis was a prime example.3 
Osteoporosis is a disease characterized by low 
bone mass and bone structure deterioration causing 
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Inclusion criteria used was hemophilic patients between 
19-50 years old, while exclusion criteria were subjects with 
prosthesis on the location examination of BMD, antiviral for 
HIV or HCV, previous or ongoing treatment of osteoporosis 
(bisphosphonate, SERM, calcitonin, strontium ranelat, 
hormone replacement therapy); routine steroid for 6 weeks 
or more, one or more comorbid such as rheumatoid arthritis, 
SLE, CKD, and patients refusing to be involved in the study. 
The variables included in the estimation were age, BMI, 
hormone replacement therapy, physical activity, clinical 
arthropaty degree, radiological arthropaty degree, HIV, HCV, 
bone density measurement, and history of fracture. BMD 
examination was done with GE Lunar Scan and the results 
were reported using Z-score. Decreased bone density was 
defi ned as Z-score -2 or less. HJHS score was estimated 
using guidelines according to International Prophylaxis 
Study Group. Knee radiologic photos were interpreted by a 
radiologist using Arnold-Hilgartner score. Score of 3 or more 
was categorized as signifi cant arthropaty. 
The data of subject characteristics is presented in tables. 
Numeric data with normal distribution is presented in mean 
+ standard deviation (SD) while abnormal distribution is 
presented in median. Categorical data is presented in amount 
(n) and percentage. Statistic processing was done using SPSS. 
RESULTS
Between June – November 2012, a tracing to 152 hemophilic 
patients living in Jabodetabek listed in Integrated Hemophilia 
Team was done. Out of 84 patients that were managed to be 
contacted, 63 of them fulfi lled inclusion criteria to be involved 
in the study. Their characteristics are seen on the table 1. 
All subjects in this study were male with median age of 
26 years old (19-46 years old) and most of them graduated 
from high school and university. 53 subjects had hemophilia A 
while the rest of them had hemophilia B and most of them had 
severe hemophilia. About 74.6% of subjects had normal BMI 
and 25.4% had low BMI. 54% subjects had Hepatitis C while 
HIV was found in 1 subject.
History of fracture was found in 14,3% of subjects. All of 
them had normal bone density and most of them (90%) were 
caused by trauma. Median BMD of those subjects was 1,159 
g/cm2 while the median BMD of subjects without any fracture 
history was 1,023 g/cm2. 
Table 1   The characteristics of the subjects in study
Variable Total (n =  63)
Age (years), median (min-max) 26 (19-46)
Age at diagnosis (month), median (min-max) 9 (1-324)
Duration since diagnosis (month), median (min-max) 268 (60-492)
Education, n (%)
- Basic (elementary - junior high school)
- Middle (senior high school) 




Body mass index (kg/m2), mean + SD 21,4 + 3,8












Substitution therapy in the last 1 month
- Factor VIII (IU), median (min-max)
- Factor IX (IU), mean + SD
2000 (0-7350)
2366,2 + 1443,4
Substitution therapy per kg body weight in the last 1 
month
- Factor VIII (IU/kg), median (min-max)
- Factor IX (IU/kg), mean + SD
35,5 (0-126,9)
39,5 + 27,5
Substitution therapy in the last 3 months
- Factor VIII (IU), median (min-max)
- Factor IX (IU), mean + SD
6000 (0 - 21550)
5469,7 + 3117,3
Substitution therapy per kg body weight in the last 3 
months 
- Factor VIII (IU/kg), median (min-max)
- Factor IX (IU/kg), mean + SD
101,1 (0-359,4)
89,8 + 57,6
BMD (g/cm2), median (min-max) 1,036 (0,808-
1,337)










Table 2   Fracture on hemophilic subjects
Variable Total (n=63)
History of fracture, n (%)
- Positive






Cause of fracture, n*
- Traffic accident
- Domestic accident 




     4 
     3 
     1 
     1 
     1 
     6 
     1  
     1
     2
54 (85,7)
Proportion of decreased bone mass density was 6.3%. 
But the results were different when using Z-score and T-score. 
Bone density characteristics of the subjects can be seen below. 
Table 3   Bone density on hemophilia 
Variabel Total subyek (n=63)
BMD (g/cm2), median (min-max) 1,036 (0,808-1,337)
Decreased bone density according to the ISCD*
Z-score < -2, n(%) 4 (6,3%)
Z-score > -2, n(%) 59 (93,7%)
osteopenia and osteoporosis according to the WHO**
     Normal (T-score>-1), n (%) 40 (70,2%)
     Osteopenia/osteoporosis (T-score <-1), n (%) 17 (29.8%)
*The criteria of decreased bone density according to the ISCD is used for males 
younger than 50 years old and pre-menopause females using cut-off Z-score < -2
** osteopenia and osteoporosis according to the WHO is used for post-menopause 
females and males older than 50 years old
All subjects with decreased bone density had hemophilia 
A, lower BMI, lower incidence of HCV or HIV infection, and 
younger compared with subjects with normal bone density. 
There was a signifi cant difference of substitution therapy 
between subjects with normal and decreased bone density. 
Subjects with decreased bone density used substitution 
therapy twice as much as subjects with normal bone density in 
the last 1 month (median 4047 IU/month vs 2000 IU/month). 
The same tendency also happened in substitutional therapy 
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use in the last 3 months (10872,5 IU vs 6632,6 IU). 
Both groups had similar level of physical activities. In decreased BMD group, their arthropaty scores were better but the 
incidence rates of knee arthropaty were similar in both groups. The subjects’ characteristics can be seen below. 
Table 4   The characteristics of subjects with decreased bone density
Variable Subjects with decreased bone 
density (n=4)
Subjects with normal bone 
density (n=59)
Age (years), median (min-max) 19 (19-21) 26 (19-46)
Age at diagnosis (months), median (min-max) 8 (1-36) 9 (1-324)











BMI (kg/m2), mean + SD 18,6 + 2,8 21,5 + 3,8
Substitution therapy in the last 1 month (IU), median (min-max) 4047 (0-6020) 2000 (0-7350)
Substitution therapy per kg body weight in the last 1 month (IU/kg), 
median (min-max)
83,4 (0-114,2) 35,5 (0-126,9)
Substitution therapy in the last 3 month (IU),mean + SD 10872,5 + 7796,9 6632,6 + 4923,3
Substitution therapy per kg body weight in the last 3 months (IU/
kg), mean + SD
213,9 + 155,9 113,3 + 83,9 
BMD (g/cm2), median (min-max) 0,900 (0,823-0,949) 1,062 (0,808-1,337)
Physical activity score (HAL score), mean + SD 69,6 + 12,8 71 + 13,4
Clinical arthropaty score (HJHS score), mean + SD 18,7 + 4,4 23,2 + 11,8
Radiologic arthropaty, n (%)
     Significant arthropaty






     Positive






     Positive





kilogram body weight in this study was 35,5 IU/kg or roughly 
around 426 IU/kg in one year. This was lower than on demand 
therapy in Taiwan as reported by Liou et al (median use of 
factor VIII 1342,1 IU/kg/year) but higher than data in report 
by Naderi et al from Iran (average use of 28,8 IU/kg/year - 
31,1 IU/kg/year).38,41 Up to this day, Iran still use on demand 
therapy for hemophilia.42 The dosage in this therapy was 10 
times lower compared with the dosage in prophylaxis therapy 
in study by Khawaji et al (median use of 4106 IU/kg/year).19
In this study, the proportion of HCV infection was 54%, 
which was quite big compared with the study done by Khawaji 
in which he reported a proportion of 26,9%.19 Other studies 
done by Wallny et al, Katsarou et al, and Gerstner et al showed 
bigger proportion of HCV infection than this study.9,18,20 The 
proportion estimated in this study was similar with a study 
done in Europe.43
There was only a subject with HIV infection (proportion 
of HIV infection 1,6%). This result was different from other 
studies reported by Khawaji et al, Linari et al, Wallny et al, 
Katsarou et al, and Gerstner et al in which the proportion of 
HIV infection was between 11,5%-40,3%.9,18,20,21,37
In this study, the proportion of decreased bone density 
in this study was 6.3% and that result was lower from other 
similar studies done outside of Indonesia and can be seen on 
DISCUSSION
There are 1,571 hemophilic children and adults in Indonesia. 
152 hemophilic adults living in Jabodetabek were listed and 
79 of them went to Hematology Oncology Outpatient Clinic 
of Cipto Mangunkusumo Hospital at least once in the last 6 
months. This was the fi rst study of bone density in hemophilic 
patients in Indonesia. 
The median age of subject in the study was 26 years old 
with range of age between 19-46 years old. This median age 
complies with the age of peak bone mass and in accordance 
with the age of subjects in previous studies.10,14,21,26,37,38 The 
eldest was 46 years old, unlike a few studies before with 
subjects older than 50 years old.18,20,21,22,37-39 The age limitation 
in this study made uniform bone density measurement possible 
according to the standard of ISCD to prevent bias caused by 
age. 
Most subjects in this study had normal or high BMI with 
average of 21.4 kg/m2 and similar with studies done by Naderi 
and Mansouritorghabeh.14,38
All subjects had on demand substitution therapy, meaning 
that factors were given only if bleeding had already happened. 
Median use of factor VIII in this study subjects was 2000 IU 
in the last 1 month or roughly around 24000 IU per year. This 
was larger than average factor VIII use in Indonesia, which 
was about 17211 IU in 2006.40 Median use of factor VIII per 
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Table 5   Decreased bone density in hemophilia
Study and location Age of subjects Decreased 
bone density 
definition
Decreased bone density proportion Referrence
Wallny et al, Germany (2007) Average age of 41,4 + 13,1 years old T-score 43,5% osteopenia, 25,8% osteoporosis σ 9
Nair et al, India (2007) Average age of 29,53 + 9,27 years old T-score 50% osteoporosis σ 10
Gerstner et al, USA (2009) Median age of 41,5 years old (18-66) T-score 43% osteopenia, 27% osteoporosis σ 18
Mansouritorghabeh et al, Iran (2009) Average age of 30,57 + 12,18 years old T-score 35,7% osteoporosis σ 50
Katsarou et al, Greek (2010) Median age of 36 (18-60) T-score 52% osteopenia, 55,6% osteoporosis σ 20
Khawaji et al, Sweden (2010) Average age of 30,5 years old T-score 40% osteopenia σ 21
Linari et al, Italy (2012) Median age of 41,5-45,8 years old** Z-score Decreased bone density by 23%*** 37
Naderi et al, Iran (2012) Average age of 27,73 + 9,5 years old T-score 50% osteoporosis, 7,5% osteopenia σ 38
Anagnostis et al, Greek (2012) Average age of 45,87 + 15,15 years old Z-score Decreased bone density by 26,9% 46
This study Median age of 26 years old (19-46) Z-score Proportion of decreased bone density of 6,3% -
σCriteria of osteopenia and osteoporosis using WHO T-score
*The study divided subjects into 2 groups with different mean age 
**The study divided subjects into 3 groups with different median age 
***Decreased bone density using Z-score< -2
table 5. This difference was possibly caused by difference 
estimation using Z-score in this study while other studies used 
T-score. Choosing Z-score in this study was based on several 
reasons. Z-score was the standard score for males younger 
than 50 years old according to the ISCD. Z-score also allows 
objective measurement and it was estimated by comparing 
bone density of subjects to those in the population, while 
T-score was estimated by comparing to density of peak bone 
mass population. The weakness of using T-score was younger 
subjects would have lower bone density and prevalence 
of decreased bone density would became higher.72 When 
adhering to the criteria by WHO, the proportion of osteopenia 
and osteoporosis was 29,8% and it was similar with previous 
studies. 
Low proportion of decreased bone density in this study gave 
new insight in studying bone density of hemophilic patients. 
This was the second study involving adult hemophilics using 
standard measurement of bone density. A study done by Linari 
et al also used Z-score, but subjects with osteopenia had 
Z-score between -1 and -2 while osteoporosis had Z-score less 
than -2.37 Its grouping method was also not in accordance to 
the guidelines from ISCD, in addition to involving subjects 
older than 50 years old.38
The difference of results between this study and of 
Linari et al could be caused by a number of factors. Linari 
et al involved older subjects with the eldest being 73 years 
old, causing higher proportion of decreased bone density. 
Another reason could be the location of study, since Europe as 
Linari’s study place had different race and sunlight exposure 
while Johnell et al reported that every 10o away from equator 
increased the risk of osteoporosis as much as 0,6%.45 
Another study done by Anagnostis et al in Greece in 
2012 used bone density measurement in accordance to the 
standard and reported decreased bone density in 26.9% of 
their subjects.46 But its limitation was involving subjects older 
than 50 years old with the eldest being 76 years old.46 The 
characteristics of subjects with decreased bone density in this 
study also different than its predecessor because they were 
younger with lower BMI compared with studies by Gerstner 
et al and Naderi et al.18,38 They also had lower incidence of 
HCV and HIV infection compared with Gerstner’s report.18 
Substitution therapy was higher compared with osteopenic 
subjects in Naderi’s report (83,4 IU/kg in 1 month vs 31,1 
IU/kg in 1 year).38 These differences in characteristics 
contributed to the different proportions of decreased bone 
density. Although there were differences found in the studies, 
it can be concluded that decreasing bone density happens in 
hemophilia.
In this study, subjects with decreased bone density were 
younger with more frequent bleeding buth similar physical 
activity scores and better joint scores than normal subjects. 
These might be because younger age meant good joints. Good 
joints allow more physical activities which contributed to 
more bleeding. 
There were 10 histories of fractures in 14.3% of subjects 
involved in the study, and it was similar with Anagnotis 
(16%) but lower than Grestner (20%), Gallacher (36,8%), 
and Khawaji (23,3%).7,18,21,46 It was bigger than Nair (12%) 
though.10 The difference could not be explained fully since 
not all studies described their location, the causes of fractures, 
and physical activity measurement. The fracture location was 
similar with Gallacher, Khawaji, and Anagnostis, in which 
most of them happened not on the bone with risk of pathologic 
fracture.18,21,46 Most of the fractures in this study (90%) were 
traumatic injuries, which explained the reason they happened in 
subjects with normal bone density. Level of physical activities 
in subjects with or without fractures was similar (average 
HAL scores 71,9 + 12,6 vs 65,4 + 16,4), meaning fractures 
happened were caused by the intensity of trauma. The causes 
of fractures in this study were different from Anagnostis report 
because they report 53% of fractures caused by mild trauma. 46 
The difference of proportion of subjects with fragility fracture 
on this study with studies by Anagnostis et al and Gerstner et 
al probably because studies by Anagnostis et al. and Gerstner 
et al included older subjects.18,46 
Gerstner et al reported 50% of fractures in subjects with 
decreased bone density while Anagnostis reported 18%.18,46 
Based on these and other studies, it seems there is no exact 
Original Article
29Indonesian Journal of Rheumatology 2013; Vol 04
explanation of decreased bone density in hemophilia as a 
cause of fracture. 
As for signifi cant age gap in this study, a report from 
Gerstner had different result because his study subjects who 
had normal bone density were 20 years younger than those 
with low bone density.18 Wallny reported that age had negative 
correlation with BMD, meaning older age had lower T-score.9 
Both of the studies’ results were different from this study 
result. This could be explained by some reasons. Subjects with 
decreased bone density in this study had lower BMI, which 
was a risk factor of osteoporosis both in hemophilic and non 
hemophilic groups. Low BMI is known to correlate with low 
peak bone mass and contributed to the loss of bone mass.4 
Wallny reported BMI to had negative correlation with bone 
density.9 Gerstner reported that their subjects with osteoporosis 
had signifi cant low BMI.18 The relationship between low BMI 
with hemophilic population was confi rmed in a metaanalysis. 
11
Another reason was subjects with decreased bone density 
used substitutional therapy twice as much as in normal subjects. 
Indonesia had on-demand therapy in hemophilia, so therapy 
could be assumed to represent bleeding incidents. This meant 
subjects with decreased bone density had more bleeding. This 
study also showed that duration of disease since diagnosis in 
subjects with low bone density was short, so it seemed that 
bleeding played more important roles in decreasing bone 
density in hemophilia. Result of this study also in accordance 
to the study by Naderi and colleague in Iran which showed that 
bleeding episodes are signifi cantly more frequent in subjects 
with osteopenia or osteoporosis.38 Results from this study and 
study by Naderi et al.38 and also Liel et al.35 suggests that there 
might be an association between bleeding and reduced bone 
density. However we still can not rule out that more bleeding 
in subjects with reduced bone density in this study is merely a 
consequence of the severity of hemophilia because all subjects 
with reduced bone density in this study were subjects with 
severe hemophilia. The association of bleeding and bone 
metabolism in hemophilia patients still needs futher studies to 
confi rm the causal association.
In this study, there was no difference of physical activity 
level between both groups, similar to a study by Khawaji in 
2009, but different from Gerstner who reported better physical 
activity in normal BMD and Anagnostis who reported 
positive correlation between physical activity score and bone 
density. 18,19,46 In Gerstner and Anagnostis studies, there was 
no explanation about bleeding frequency or substitutional 
therapy. Khawaji in 2010 reported signifi cant correlation 
between duration and the intensity of physical acitivities with 
bone density, but this could only be applied to heavy activities 
and not related to total activities.21 This study used HAL score 
to measure total activities by subjects and caused different 
results.
Knee arthropaty was also important because it was the 
most common place for hemarthrosis and had great impact 
in mobility. The incidence of knee arthropaties was similar 
in both groups, and this result was different from the result in 
Anagnostis study. 
In this study, HIV infection was lower and found in a 
subject with decreased bone density. This was different than 
the result in studies by Gerstner, Katsarou, and Anagnostis, 
and it could be caused by the possibility of early diagnosis in 
those countries since transfusions were done early. This study 
only had a subject with HIV (1,6%), compared with Gerstner 
(37%), Anagnostis (38.9%), and Katsarou (6,7%).18,20,46 A 
possible explanation for low HIV infection in hemophilia 
could be because of unmeasured role of cytokine proresorption 
TNF-α as the base of decreased bone density. 
The subjects in this study had lower HCV infection than 
studies by Wallny, Gerstner, and Anagnostis.9,18,46 Nair and 
Khawaji did not fi nd the relationship between HCV and low 
bone density.10,19 This difference could be caused by different 
level of liver fi brosis and viral load, which have not been 
studied.28,47
There were things that have not been studied yet, such 
as proinfl ammation cytokine, bone resorption and formation 
marker, relationship between independent variable and bone 
density, direct role of factor VIII defi ciency to bone density, 
and patophysiology of decreased bone density in hemophilia. 
Considering the role of factor VIII in inhibition of RANKL 
and its synergic action with OPG, osteoclast activity is needed 
to be understood in people with factor VIII defi ciency. The 
relationship between factor VIII and osteoclastogenesis 
also needs to be understood because the main treatment 
of osteoporosis is bisphosponate, which inhibits the role of 
osteoclast.
Other factors in bone metabolism and patophysiology 
of decreased bone density are also need to be considered. 
Gerstner and Anagnostis found an association between bone 
density with vitamin D in hemophilia.18 Other studies by 
Gowda, Anagnostis, and Linari found vitamin D defi ciency in 
majority of hemophilic subjects, both in adults and children. 
37,46,48 
The study limitation was its cross-sectional design, 
because it could not defi ne the causal relationship between 
variables. Its descriptive trait also denied any quantifi cation 
of association between variables. Another limitation in this 
study was no examination of inhibitor, vitamin D, and bone 
metabolism done because of the limited fund. Nonetheless, this 
study points out that reduced bone density actually happened 
in hemophilia patients although the prevalence probably not 
as high as previous reports.
CONCLUSION
The proportion of decreased bone density in adult hemophilic 
subjects was 6.3%, with all of them had hemophilia A. Subjects 
with decreased bone density were younger, had lower BMI, 
had more substitution therapy, better arthropaty score, and 
lower incidence of blood transmitted infection compared with 
subjects with normal bone density. 
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